Restricted Antimicrobial Pager 2013-2014. Restricted Antimicrobials Amikacin* Amphotericin, liposomal Amphotericin (Inhaled) Artemether/lumefantrine Atovaquone.

Slides:



Advertisements
Similar presentations
Improving IV antibiotic use; the role of the nurse
Advertisements

TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Monotherapy Versus Combination Therapy
Edward L. Goodman, MD Core Faculty Hospital Epidemiologist June 27, 2013.
QUINOLONE RESTRICTION AT MARLBOROUGH HOSPITAL. Vibha Sharma, M.D. Infectious disease consultant and Medical director, infection control, Marlborough hospital.
CARBAPENEMS e.g. Imipenem / Cilastatin Meropenem
Antibiotic treatment choices for SBP Treviso 8 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.
Choice of Antibiotics in Diverticulitis Jeff Poynter University of Michigan Medical School Jeff Poynter University of Michigan Medical School.
Emerging Antimicrobial Resistance in Texas The new ESBLs.
Enoch Omonge University of Nairobi
National Changes in Antibiotic Policy R. Andrew Seaton Consultant Physician Lead doctor Antimicrobial Management Team, NHS GG&C.
CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.
ANTIBIOTICS.
Management of Neutropenic Fevers in cancer patients Jerry Yu.
Edi Hartoyo Alan R. Tumbelaka Infectious Disease and Tropical Pediatrics Working Group Indonesian Pediatrician Society 1.
Antimicrobial Stewardship Program JMH House staff Orientation 2012 Lilian Abbo, MD Assistant Professor Clinical Infectious Diseases Laura Smith, PharmD.
How to Start an Antimicrobial Stewardship Program
Antimicrobial Stewardship: Focus on IV to PO Antibiotics Michaelia Dunn, Pharm.D., BCPS Clinical Pharmacist, IUAH February 22 nd, 2012
Evidence Based Guidelines at PHD related to Infectious Disease Edward L. Goodman, MD.
Bugs and Drugs: Solving the Antibiotic Dilemma Catherine Davis, Pharm.D. Exempla Saint Joseph Hospital.
Optimizing Antibiotics Dr Samir Sahu. Time to Antimicrobial Therapy KHL.
Practical Prescribing Session Berny Baretto (Antibiotic Pharmacist) 30 th August 2012.
Warren S. Joseph, DPM, FIDSA Roxborough Memorial Hospital, Phila., PA
MDR Organisms in Holy Family Hospital Rawalpindi
Antibiotic Pearls in the Emergency Department
Mike Jones Vice President, Royal College of Physicians of Edinburgh.
Smart use of antibiotics: building confidence in new approaches Dr. Hayley Wickens.
DHS/PP Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle.
Antimicrobial Stewardship in Long Term Care Shira Doron, MD Assistant Professor of Medicine Associate Hospital Epidemiologist Tufts Medical Center.
Shira Doron, MD Assistant Professor of Medicine
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
INF 1 ® Life-Threatening Infections INF 1 ®. INF 2 ® Objectives Recognize predisposing conditions for infection Identify clinical manifestations of infection.
Review of Antibiotics Zagorka Popovski, Pharm.D. Clinical Pharmacist, Intensive Care.
Update in Infectious Diseases 2012
Selection of an optimal antifungal for treatment of invasive aspergillosis: susceptibility/resistance, adverse reactions, drug interactions John Bennett,
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Chapter 17 Anti-Infective Drugs. Copyright © 2007 by Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Treatment by Anti-Infectives Need to identify causative.
General Principles of Antimicrobial Therapy. Concept #1: The guiding principle of antibiotic selection Antibiotic coverage should be kept to the narrowest.
Common ID Syndromes March 2014.
Impetigo The best topical agent is mupirocin; other agents, such as bacitracin and neomycin, are less effective. Patients who have numerous lesions or.
How Clinicians Use Data For Clinical Decision Making March 5, 2003 Anti-Infective Drug Advisory Committee How Clinicians Use Data For Clinical Decision.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Let’s Really Implement Antimicrobial Stewardship Chris Gentry, Pharm.D., BCPS Clinical Coordinator and Clinical Specialist, Infectious Diseases Oklahoma.
Empirical Therapy for Ventilation Associated Pneumonia Azar. Hadadi Associate Professor of Infectious Diseases.
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Antibiotics Affecting the Bacterial Cell Wall
Impetigo Mupirocin; (bacitracin and neomycin, are less effective.) numerous lesions or not responding to topical agents: oral antimicrobials effective.
Managing Candidemia JEANNE FORRESTER, PHARMD, BCPS PGY2 INFECTIOUS DISEASES PHARMACY RESIDENT MEDICAL UNIVERSITY OF SOUTH CAROLINA.
Slide 1 Mosby items and derived items © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 46 Antimicrobial Agents.
Guideline for the Diagnosis and Management of Adults in LTC with Urinary Tract Infection (Part 2) This is intended as a guide for evidence-based decision-making.
Antibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center.
MANAGEMENT OF NEUTROPENIC FEVERS IN CANCER PATIENTS Jerry Yu.
Internal Medicine Mini-Lecture. Learning Points  Basics  Choosing antibiotics  Overview.
HAP and VAP Guidelines Update
Cephalosporins Four Generations! Bactericidal & Time-Dependent!
Therapeutics III Tutoring February 10th, 2016
The Role of the Microbiology Laboratory in AMS programs
Average susceptibility
Interior Health Pharmacy Resident Kootenay Lake Hospital
Intro to Antibiotics By: Alaina Darby.
به نام خدا.
Strategies and Implementation: Pre-authorization vs. Post-prescription
Introduction to Antimicrobial Stewardship: Bugs and Drugs
CAP Therapy Babak Sayad Associate Professor of Infectious Diseases
Presentation Title 36pt Arial Bold
New approach to Cefazolin
CQUIN 2 Overview CQUIN ‘Commissioning for Quality and Innovation’
When and How to Treat UTI Section 2: How to Treat
Introduction.
Presentation transcript:

Restricted Antimicrobial Pager

Restricted Antimicrobials Amikacin* Amphotericin, liposomal Amphotericin (Inhaled) Artemether/lumefantrine Atovaquone Aztreonam Cefotaxime Ceftaroline Ceftazidime Cidofovir* Colistin (IV)* Daptomycin Entecavir Ertapenem Fidaxomicin Foscarnet* Ganciclovir Imipenem Itraconazole Ivermectin Linezolid Maraviroc Meropenem Micafungin Moxifloxacin Nitazoxanide Pentamidine Posaconazole* Quinine Quinupristin/dalfopristin Ribavirin (Inhaled)* Rimantadine Ticarcillin/Clavulanate Tigecycline Tobramycin (Inhaled) Voriconazole

Approximately 5-6 pages per day 8AM-8PM Most Commonly Requested Antimicrobials

Updated: Selected Antimicrobials That Should Not be Approved by Pager Service Agents are marked with asterisk in policy document Agents chosen due to toxicity or cost Amikacin Cidofovir Colistin (IV) Foscarnet Posaconazole Ribavirin (Inhaled)

Approval Log Located in MGH ASP (antimicrobial stewardship) folder –Daily (if possible) upload or to Christy Purpose: –To keep an accurate log of approvals/indications –Stewardship team insight (since lack of formal note providing indication/purpose) –Follow up on empiric approvals (either you or Christy)

Approval Log

Approval Log (VPN View) Network Places or Computer  MGH_ASP  Approval Pager

Approval Log

Empty form = spreadsheet for you to fill out Master List = all previous requests (updated by Christy) Upload your file with your name & date as seen below

Approval Log Can’t find the ASP folder?  your approval log to Christy –Q 24h-48hrs preferred Feel free to Christy requests to follow up –i.e. did team D/C my antibiotic as I requested? –i.e. did team narrow therapy when cultures finalized?

Stewardship Strategies Bring forward questions or unusual practices so we can work on unifying approval process –Ex. In previous year, rising number of requests for linezolid based on VRE rectal swab Give durations of 72 hrs with empiric approvals with request to follow up with you or ID consult

Common Requests and Clinical Pearls

Linezolid VRE UTI (30% of requests) –Clarify if true infection –If susceptible, amoxicillin, doxycycline and fosfomycin are less expensive alternatives Positive VRE rectal swab –Low PPV 25%, high NPV 98% –If approving, limit to 72hr approval only

Linezolid HCAP –No mortality benefit in linezolid vs vancomycin for nosocomial PNA Vanco allergy and wound infection/cellulitis –Recommend ceftaroline if possible ($80 vs $200) Wunderlink et al. Clin Infect Dis Mar 1;54(5):621-9

Linezolid Recommend PO if patient has no GI absorption issues (highly bioavailable) –If sepsis, consider IV for first dose, and PO for remaining IV to PO ratio is 1:1, goal is 1:4

Carbapenems Necrotizing pancreatitis –No evidence carbapenem is clinically superior (OK to use in culture documented/history of ESBL) –Agents with best penetration: fluoroquinolones, imipenem, ceftazidime, cefepime, metronidazole, clindamycin, chloramphenicol, doxycycline, and fluconazole PCN or cephalosporin allergy –Run through PCN & Ceph Hypersensitivity Pathway Powell JJ et al. Br J Surg. 1998;85: Buchler M, et al. Gastroenterology. 1992;103: Gloor B et al. 2003;26: Shrikhande S et al. Antimicrob Agents Chemother. 2000;44: Bassi C et al. Antimicrob Agents Chemother. 1994;38:

Aztreonam PCN or cephalosporin allergy –Run through PCN & Ceph Hypersensitivity Pathway PSA: –76% susceptible to aztreonam –89% susceptible to cefepime –91% susceptible to ceftazidime

Micafungin QT prolongation fear with azoles –Usually due to drug interactions and multiple QT prolonging drugs with underlying pt risk factors –Azoles unlikely to prolong QT on their own Resistant Candida in urine –Does NOT penetrate into urine –May be okay in upper UTIs

Ceftazidime Globe rupture – approve CNS – approve HD dosing –Renal service likes ceftaz 2g q HD –Note: can also give cefepime 2g q HD Perez, K. Am J Kidney Dis. 2012;59(5):

Voriconazole Resistant UTIs –Does NOT reach urine –May be okay for upper UTIs

Moxifloxacin Restricted to Tuberculosis More costly than other quinolones “Anaerobic coverage” –Poor; recommend levofloxacin/ciprofloxacin plus metronidazole/clindamycin

Other Tips Curbsides: defer to ID consult pager Ask if attending of record has ID privileges –i.e. SICU, MICU, cystic fibrosis, lung transplant –Refer to restricted antimicrobial policy for list of ID approvers Posaconazole is restricted to transplant ID only